|
Re: Looking over Amarin does lead to one obvious conclusion...
|
1
|
Resverlogix Corp.
|
Feb 14, 2019 05:18PM
|
|
Re: Resverlogix Provides Update on BETonMACE Phase 3 Trial
|
1
|
Resverlogix Corp.
|
Sep 16, 2019 10:08AM
|
|
Re: EASD 2019 Sept 16-20, 2019
|
1
|
Resverlogix Corp.
|
Jul 19, 2019 10:00AM
|
|
Re: What if BETonMACE had more CKD patients?
|
1
|
Resverlogix Corp.
|
Dec 27, 2019 01:12AM
|
|
Re: Food For Thought
|
1
|
Resverlogix Corp.
|
Oct 19, 2019 10:18AM
|
|
Re: 50 day moving average is $3.18
|
1
|
Resverlogix Corp.
|
Jan 16, 2019 12:45PM
|
|
Re: Brd4 Inflammation Psoriasis
|
1
|
Resverlogix Corp.
|
May 08, 2019 08:30AM
|
|
Re: Deadlines missed? Results Late? Not really.
|
1
|
Resverlogix Corp.
|
Jan 12, 2019 04:51PM
|
|
Re: Connection issues again
|
1
|
Resverlogix Corp.
|
Dec 06, 2019 08:15AM
|
|
Re: Patient Years & MACE rate Question
|
1
|
Resverlogix Corp.
|
Jul 11, 2019 09:16AM
|
|
Re: eGFR and Cognition?
|
2
|
Resverlogix Corp.
|
Nov 22, 2019 05:10PM
|
|
Re: SA blog post for those interested.....
|
2
|
Resverlogix Corp.
|
Apr 17, 2019 08:44AM
|
|
Re: Recent rise in SP...
|
2
|
Resverlogix Corp.
|
Sep 28, 2020 12:16PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 03:45PM
|
|
Better than averagd volumd today
|
2
|
Resverlogix Corp.
|
Feb 04, 2019 03:18PM
|
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 20, 2020 09:53AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 11:15AM
|
|
Re: June 21, 2018.
|
2
|
Resverlogix Corp.
|
Jun 09, 2020 12:41PM
|
|
Don't look now but...
|
2
|
Resverlogix Corp.
|
May 08, 2019 09:56AM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 25, 2019 12:48PM
|
